39246712|t|Single-domain magnetic particles with motion behavior under electromagnetic AC and DC fields are a fatal cargo in Metropolitan Mexico City pediatric and young adult early Alzheimer, Parkinson, frontotemporal lobar degeneration and amyotrophic lateral sclerosis and in ALS patients.
39246712|a|Metropolitan Mexico City (MMC) children and young adults exhibit overlapping Alzheimer and Parkinsons' diseases (AD, PD) and TAR DNA-binding protein 43 pathology with magnetic ultrafine particulate matter (UFPM) and industrial nanoparticles (NPs). We studied magnetophoresis, electron microscopy and energy-dispersive X-ray spectrometry in 203 brain samples from 14 children, 27 adults, and 27 ALS cases/controls. Saturation isothermal remanent magnetization (SIRM), capturing magnetically unstable FeNPs ~ 20nm, was higher in caudate, thalamus, hippocampus, putamen, and motor regions with subcortical vs. cortical higher SIRM in MMC <= 40y. Motion behavior was associated with magnetic exposures 25-100 mT and children exhibited IRM saturated curves at 50-300 mT associated to change in NPs position and/or orientation in situ. Targeted magnetic profiles moving under AC/AD magnetic fields could distinguish ALS vs. controls. Motor neuron magnetic NPs accumulation potentially interferes with action potentials, ion channels, nuclear pores and enhances the membrane insertion process when coated with lipopolysaccharides. TEM and EDX showed 7-20 nm NP Fe, Ti, Co, Ni, V, Hg, W, Al, Zn, Ag, Si, S, Br, Ce, La, and Pr in abnormal neural and vascular organelles. Brain accumulation of magnetic unstable particles start in childhood and cytotoxic, hyperthermia, free radical formation, and NPs motion associated to 30-50 muT (DC magnetic fields) are critical given ubiquitous electric and magnetic fields exposures could induce motion behavior and neural damage. Magnetic UFPM/NPs are a fatal brain cargo in children's brains, and a preventable AD, PD, FTLD, ALS environmental threat. Billions of people are at risk. We are clearly poisoning ourselves.
39246712	171	180	Alzheimer	Disease	MESH:D000544
39246712	182	191	Parkinson	Disease	MESH:D010302
39246712	193	226	frontotemporal lobar degeneration	Disease	MESH:D057174
39246712	231	260	amyotrophic lateral sclerosis	Disease	MESH:D000690
39246712	268	271	ALS	Disease	MESH:D008113
39246712	272	280	patients	Species	9606
39246712	359	393	Alzheimer and Parkinsons' diseases	Disease	MESH:D010300
39246712	395	397	AD	Disease	MESH:D010300
39246712	399	401	PD	Disease	MESH:D010300
39246712	407	433	TAR DNA-binding protein 43	Gene	23435
39246712	676	679	ALS	Disease	MESH:D008113
39246712	1155	1157	AD	Disease	MESH:D010300
39246712	1192	1195	ALS	Disease	MESH:D008113
39246712	1385	1404	lipopolysaccharides	Chemical	MESH:D008070
39246712	1436	1438	Fe	Chemical	MESH:D007501
39246712	1440	1442	Ti	Chemical	MESH:D014025
39246712	1444	1446	Co	Chemical	MESH:D003035
39246712	1448	1450	Ni	Chemical	MESH:D009532
39246712	1452	1453	V	Chemical	MESH:D014639
39246712	1455	1457	Hg	Chemical	MESH:D008628
39246712	1459	1460	W	Chemical	MESH:D014414
39246712	1462	1464	Al	Chemical	MESH:D000535
39246712	1466	1468	Zn	Chemical	MESH:D015032
39246712	1470	1472	Ag	Chemical	MESH:D012834
39246712	1474	1476	Si	Chemical	MESH:D012825
39246712	1478	1479	S	Chemical	MESH:D013455
39246712	1481	1483	Br	Chemical	MESH:D001966
39246712	1485	1487	Ce	Chemical	MESH:D002563
39246712	1489	1491	La	Chemical	MESH:D007811
39246712	1497	1499	Pr	Chemical	MESH:D011221
39246712	1617	1626	cytotoxic	Disease	MESH:D064420
39246712	1628	1640	hyperthermia	Disease	MESH:D005334
39246712	1828	1841	neural damage	Disease	MESH:D015441
39246712	1925	1927	AD	Disease	MESH:D010300
39246712	1929	1931	PD	Disease	MESH:D010300
39246712	1933	1937	FTLD	Disease	MESH:D057174
39246712	1939	1942	ALS	Disease	MESH:D008113

